DE1251314B - - Google Patents

Info

Publication number
DE1251314B
DE1251314B DENDAT1251314D DE1251314DA DE1251314B DE 1251314 B DE1251314 B DE 1251314B DE NDAT1251314 D DENDAT1251314 D DE NDAT1251314D DE 1251314D A DE1251314D A DE 1251314DA DE 1251314 B DE1251314 B DE 1251314B
Authority
DE
Germany
Prior art keywords
acid
lactone
oxysteroid
mixture
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DENDAT1251314D
Other languages
German (de)
English (en)
Publication of DE1251314B publication Critical patent/DE1251314B/de
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
DENDAT1251314D Pending DE1251314B (cg-RX-API-DMAC7.html)

Publications (1)

Publication Number Publication Date
DE1251314B true DE1251314B (cg-RX-API-DMAC7.html)

Family

ID=604702

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1251314D Pending DE1251314B (cg-RX-API-DMAC7.html)

Country Status (1)

Country Link
DE (1) DE1251314B (cg-RX-API-DMAC7.html)

Similar Documents

Publication Publication Date Title
DE1152101B (de) Verfahren zur Herstellung von mit einem Pyrazolring kondensierten Steroidverbindungen
DE1251314B (cg-RX-API-DMAC7.html)
DD144269A5 (de) Verfahren zur herstellung von steroidverbindungen
CH494216A (de) Verfahren zur Herstellung von in 3-Stellung einer verätherte Hydroxygruppe tragenden 6-Aminomethyl- 3,5-steroiden
CH537913A (de) Verfahren zur Herstellung von 5(10)-Keto-19-nor-steroiden
DE1593501A1 (de) 15,16ss-Methylensteroide der 19-Nor-androstan-Reihe
DE1418945C3 (de) Verfahren zur Herstellung von 16 alpha Methyl 17alpha hydroxy 20 oxo pregnandenvaten
US2530389A (en) Adducts of bisnor-5, 7, 9(11)-cholatrien-22-al-3-one
EP0039893B1 (de) Verfahren zum Abbau der C-20-Carboxylgruppe in delta-4- und gegebenenfalls weitere Doppelbindungen enthaltenden BNC-Verbindungen sowie neue C-21-Steroide
DE1264441B (de) Verfahren zur Herstellung von 17alpha-AEthinyl-delta 5(10-19-nor-androsten-17beta-ol-3-on und 17alpha-AEthynil-19-nor-testosteron sowie dessen Estern
EP1163257B1 (de) Verfahren zur herstellung von 4,4- dimethyl -3beta- hydroxypregna -8,14-dien-21- carbonsäureestern und zwischenprodukte im verfahren
DE833961C (de) Verfahren zur Herstellung von Progesteron
DE1618747C3 (de) Verfahren zur Herstellung von Delta hoch 5(10) 3-Keto-19-nor-steroiden
CH500958A (de) Verfahren zur Herstellung von Steroidverbindungen
EP0000368B1 (de) D-Homosteroide und solche enthaltende Präparate sowie Verfahren zur Herstellung solcher D-Homosteroide
DE1668687A1 (de) Neue 18-Methyl-5alpha-H-androstane
DE948974C (de) Verfahren zur Herstellung von cyclischen 4-Halogenpregnan-3, 20-dion-3, 20-diketalen
DE1593407C3 (de) 17beta-Hydroxy-2-oxaöstra-4,9(10)dien-3-on sowie Verfahren zur Herstellung dieser Verbindung
AT257060B (de) Verfahren zur Herstellung von neuen 3-Enoläthern der 6-Methyl-3-oxo-Δ<4>-steroide der Androstan-, 19-Norandrostan-, Pregnan- und 19-Norpregnanreihe
CH505809A (de) Verfahren zur Herstellung 1(10)-5-oxo-5,10-Seco-steroiden
WO1998004579A1 (de) Verfahren zur herstellung von 3-sulfanato-oxy-estra-1,3,5(10)-trien-derivaten ii
DE2001262A1 (de) 19-Homosteroide
DE1164402B (de) Verfahren zur Einfuehrung einer Sauerstofffunktion in Steroide
DE2508110A1 (de) Verfahren zur gewinnung von 19-nor-delta hoch 4 -androsten-3,17- dion
DE1418856A1 (de) Steroide und Verfahren zu ihrer Herstellung